These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 9846570)

  • 1. G-quadruplex DNA: a target for drug design.
    Mergny JL; Hélène C
    Nat Med; 1998 Dec; 4(12):1366-7. PubMed ID: 9846570
    [No Abstract]   [Full Text] [Related]  

  • 2. NMR-Based model of a telomerase-inhibiting compound bound to G-quadruplex DNA.
    Fedoroff OY; Salazar M; Han H; Chemeris VV; Kerwin SM; Hurley LH
    Biochemistry; 1998 Sep; 37(36):12367-74. PubMed ID: 9730808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New highly hydrosoluble and not self-aggregated perylene derivatives with three and four polar side-chains as G-quadruplex telomere targeting agents and telomerase inhibitors.
    Franceschin M; Pascucci E; Alvino A; D'Ambrosio D; Bianco A; Ortaggi G; Savino M
    Bioorg Med Chem Lett; 2007 May; 17(9):2515-22. PubMed ID: 17317176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of human telomerase by a G-quadruplex-interactive compound.
    Sun D; Thompson B; Cathers BE; Salazar M; Kerwin SM; Trent JO; Jenkins TC; Neidle S; Hurley LH
    J Med Chem; 1997 Jul; 40(14):2113-6. PubMed ID: 9216827
    [No Abstract]   [Full Text] [Related]  

  • 5. Human telomerase inhibition by regioisomeric disubstituted amidoanthracene-9,10-diones.
    Perry PJ; Reszka AP; Wood AA; Read MA; Gowan SM; Dosanjh HS; Trent JO; Jenkins TC; Kelland LR; Neidle S
    J Med Chem; 1998 Nov; 41(24):4873-84. PubMed ID: 9822556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G-quadruplexes as therapeutic targets.
    Neidle S; Read MA
    Biopolymers; 2000-2001; 56(3):195-208. PubMed ID: 11745111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective interactions of perylene derivatives having different side chains with inter- and intramolecular G-quadruplex DNA structures. A correlation with telomerase inhibition.
    Rossetti L; Franceschin M; Schirripa S; Bianco A; Ortaggi G; Savino M
    Bioorg Med Chem Lett; 2005 Jan; 15(2):413-20. PubMed ID: 15603964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tri-, tetra- and heptacyclic perylene analogues as new potential antineoplastic agents based on DNA telomerase inhibition.
    Sissi C; Lucatello L; Paul Krapcho A; Maloney DJ; Boxer MB; Camarasa MV; Pezzoni G; Menta E; Palumbo M
    Bioorg Med Chem; 2007 Jan; 15(1):555-62. PubMed ID: 17035038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated assembly of G-quadruplex structures by a small molecule.
    Han H; Cliff CL; Hurley LH
    Biochemistry; 1999 Jun; 38(22):6981-6. PubMed ID: 10353809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The different biological effects of telomestatin and TMPyP4 can be attributed to their selectivity for interaction with intramolecular or intermolecular G-quadruplex structures.
    Kim MY; Gleason-Guzman M; Izbicka E; Nishioka D; Hurley LH
    Cancer Res; 2003 Jun; 63(12):3247-56. PubMed ID: 12810655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between ligand aggregation and G-quadruplex DNA selectivity in a series of 3,4,9,10-perylenetetracarboxylic acid diimides.
    Kern JT; Thomas PW; Kerwin SM
    Biochemistry; 2002 Sep; 41(38):11379-89. PubMed ID: 12234180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescence-based melting assays for studying quadruplex ligands.
    De Cian A; Guittat L; Kaiser M; Saccà B; Amrane S; Bourdoncle A; Alberti P; Teulade-Fichou MP; Lacroix L; Mergny JL
    Methods; 2007 Jun; 42(2):183-95. PubMed ID: 17472900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G-quadruplexes as targets for drug design.
    Hurley LH; Wheelhouse RT; Sun D; Kerwin SM; Salazar M; Fedoroff OY; Han FX; Han H; Izbicka E; Von Hoff DD
    Pharmacol Ther; 2000 Mar; 85(3):141-58. PubMed ID: 10739869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiological relevance of telomeric G-quadruplex formation: a potential drug target.
    Oganesian L; Bryan TM
    Bioessays; 2007 Feb; 29(2):155-65. PubMed ID: 17226803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based design of benzylamino-acridine compounds as G-quadruplex DNA telomere targeting agents.
    Martins C; Gunaratnam M; Stuart J; Makwana V; Greciano O; Reszka AP; Kelland LR; Neidle S
    Bioorg Med Chem Lett; 2007 Apr; 17(8):2293-8. PubMed ID: 17276687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of unwinding of G-quadruplex structures by Sgs1 helicase in the presence of N,N'-bis[2-(1-piperidino)ethyl]-3,4,9,10-perylenetetracarboxylic diimide, a G-quadruplex-interactive ligand.
    Han H; Bennett RJ; Hurley LH
    Biochemistry; 2000 Aug; 39(31):9311-6. PubMed ID: 10924124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quadruplex DNA crystal structures and drug design.
    Neidle S; Parkinson GN
    Biochimie; 2008 Aug; 90(8):1184-96. PubMed ID: 18395014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [G-quadruplex DNA: myth or reality?].
    Riou JF; Gomez D; Lemarteleur T; Trentesaux C
    Bull Cancer; 2003 Apr; 90(4):305-13. PubMed ID: 12801813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cationic porphyrins as G-quadruplex interactive agents in human tumor cells.
    Izbicka E; Wheelhouse RT; Raymond E; Davidson KK; Lawrence RA; Sun D; Windle BE; Hurley LH; Von Hoff DD
    Cancer Res; 1999 Feb; 59(3):639-44. PubMed ID: 9973212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aminoacyl-anthraquinone conjugates as telomerase inhibitors: synthesis, biophysical and biological evaluation.
    Zagotto G; Sissi C; Lucatello L; Pivetta C; Cadamuro SA; Fox KR; Neidle S; Palumbo M
    J Med Chem; 2008 Sep; 51(18):5566-74. PubMed ID: 18754611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.